I mentioned last week that counsel on cases (friends of mine) had file the Petition - looks like it will be argued next month.
Early indications? Plaintiffs' lawyers want it in Las Vegas.
![Reblog this post [with Zemanta]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_up7PUZXtfYb66Xla-Wp5VTxSkocg9zsM1CFHtZGczZ3qgFYuOLkJIVEzqDm4Uqjl3LEUOKA_Gg3XKaxHoDqTkAYLDilFAS4XURVdXe7sS6_OsTkiAUU9bUPyCbEu8BAVaTeS9glIcbLAa1_QStl2lQ=s0-d)
Showing posts with label U.S. Food and Drug Administration. Show all posts
Showing posts with label U.S. Food and Drug Administration. Show all posts
Thursday, April 30, 2009
Reglan: MDL Petition to be Heard on 5/28 in Louisville, KY
Link to the Order here.
I mentioned last week that counsel on cases (friends of mine) had file the Petition - looks like it will be argued next month.
Early indications? Plaintiffs' lawyers want it in Las Vegas.
I mentioned last week that counsel on cases (friends of mine) had file the Petition - looks like it will be argued next month.
Early indications? Plaintiffs' lawyers want it in Las Vegas.
Monday, April 13, 2009
FDA stops firm marketing unapproved cold medicines
Federal regulators have secured a court order barring a New Jersey pharmaceutical company from distributing more than 50 unapproved cough and cold medicines.
The Food and Drug Administration said Advent Pharmaceuticals continued to market the medications despite prior warnings from regulators. The company also failed to correct numerous manufacturing problems identified by FDA inspectors.
Drug manufacturers in the U.S. are required to submit their products to the FDA for premarket approval to guarantee they are safe and effective. The unapproved products marketed by Advent and its subsidiary Neilgen Pharmaceuticals include: BP Allergy Junior Suspension, RE All 12 Suspension and many others.
Source here.
![Reblog this post [with Zemanta]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vQ6iSZvHA_VGw7pfnv7awfEbe_8PZatdeCLP4tg54MXtGEsRDiXlq5iI7QOg9AT55zEM5AwfM8U5RdhzO8-nm1X3J9UAm_4r_EOmQyr3VDsMnX2MiggYK3v-rEKTWns4oaYjoEKj0ZA1RHho19ybaF=s0-d)
The Food and Drug Administration said Advent Pharmaceuticals continued to market the medications despite prior warnings from regulators. The company also failed to correct numerous manufacturing problems identified by FDA inspectors.
Drug manufacturers in the U.S. are required to submit their products to the FDA for premarket approval to guarantee they are safe and effective. The unapproved products marketed by Advent and its subsidiary Neilgen Pharmaceuticals include: BP Allergy Junior Suspension, RE All 12 Suspension and many others.
Source here.
Subscribe to:
Posts (Atom)